• SENSEX
    NIFTY 50
Healthcare

Cadila receives tentative USFDA nod for Apremilast tablets

Updated : November 18, 2019 08:22 AM IST

The company has received the tentative approval from the USFDA to market the tablets in the strengths of 10 mg, 20 mg, and 30 mg.
With this, the group now has 276 approvals.
Cadila receives tentative USFDA nod for Apremilast tablets
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV